Efficacy and Safety of Yanggan Jian in Hepatitis B Virus-related Decompensated Cirrhosis: A Randomized, Double-blind, Controlled Trial.

Long ChenChaoqun ZhaoWeili YaoWei LiuHua ZhangYongping MuHong CaiDongying XueChengbao WangWan'e WangYuehong LinJiamei ChenPing Liu

Published in: Journal of clinical and translational hepatology (2022)

YGJ significantly improved CTP scores and hepatic synthetic and reserve function in patients with HBV-related decompensated cirrhosis, and was safe and well tolerated.

Keyphrases

hepatitis b virus
liver failure
heart failure
double blind
clinical trial
study protocol
randomized controlled trial
atrial fibrillation
drug induced